Key Details
Price
$19.70Annual ROE
-247.45%Beta
1.39Events Calendar
Next earnings date:
May 6, 2025Recent quarterly earnings:
Feb 20, 2025Recent annual earnings:
Feb 20, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 2, 2012Analyst ratings
Recent major analysts updates
Feb 26, 25 JP Morgan
OverweightFeb 24, 25 Citigroup
BuyFeb 21, 25 Cantor Fitzgerald
OverweightFeb 12, 25 Scotiabank
Sector OutperformFeb 12, 25 Evercore ISI Group
OutperformFeb 12, 25 Canaccord Genuity
BuyJan 15, 25 HC Wainwright & Co.
BuyNov 14, 24 Piper Sandler
NeutralNov 1, 24 Scotiabank
Sector OutperformNov 1, 24 Barclays
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Travere Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Travere Therapeutics?
- Does Travere Therapeutics pay dividends?
- What sector is Travere Therapeutics in?
- What industry is Travere Therapeutics in?
- What country is Travere Therapeutics based in?
- When did Travere Therapeutics go public?
- Is Travere Therapeutics in the S&P 500?
- Is Travere Therapeutics in the NASDAQ 100?
- Is Travere Therapeutics in the Dow Jones?
- When was Travere Therapeutics's last earnings report?
- When does Travere Therapeutics report earnings?
- Should I buy Travere Therapeutics stock now?
What is the ticker symbol for Travere Therapeutics?
The ticker symbol for Travere Therapeutics is NASDAQ:TVTX
Does Travere Therapeutics pay dividends?
No, Travere Therapeutics does not pay dividends
What sector is Travere Therapeutics in?
Travere Therapeutics is in the Healthcare sector
What industry is Travere Therapeutics in?
Travere Therapeutics is in the Biotechnology industry
What country is Travere Therapeutics based in?
Travere Therapeutics is headquartered in United States
When did Travere Therapeutics go public?
Travere Therapeutics's initial public offering (IPO) was on November 8, 2012
Is Travere Therapeutics in the S&P 500?
No, Travere Therapeutics is not included in the S&P 500 index
Is Travere Therapeutics in the NASDAQ 100?
No, Travere Therapeutics is not included in the NASDAQ 100 index
Is Travere Therapeutics in the Dow Jones?
No, Travere Therapeutics is not included in the Dow Jones index
When was Travere Therapeutics's last earnings report?
Travere Therapeutics's most recent earnings report was on Feb 20, 2025
When does Travere Therapeutics report earnings?
The next expected earnings date for Travere Therapeutics is May 6, 2025
Should I buy Travere Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions